293 related articles for article (PubMed ID: 10955782)
21. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
[TBL] [Abstract][Full Text] [Related]
22. Activity and toxicity of oxaliplatin and bolus fluorouracil plus leucovorin in pretreated colorectal cancer patients: a phase II study.
Ferraresi V; Giampaolo MA; Gabriele A; Mansueto G; Buccilli A; Giannarelli D; Ciccarese M; Gamucci T
J Exp Clin Cancer Res; 2005 Jun; 24(2):187-96. PubMed ID: 16110750
[TBL] [Abstract][Full Text] [Related]
23. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
François E; Berdah JF; Chamorey E; Lesbats G; Teissier E; Codoul JF; Badetti JL; Hébert C; Mari V
Cancer Chemother Pharmacol; 2008 Nov; 62(6):931-6. PubMed ID: 18273618
[TBL] [Abstract][Full Text] [Related]
24. Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.
Sørbye H; Glimelius B; Berglund A; Fokstuen T; Tveit KM; Braendengen M; Øgreid D; Dahl O
J Clin Oncol; 2004 Jan; 22(1):31-8. PubMed ID: 14701765
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
Chau I; Norman AR; Cunningham D; Iveson T; Hill M; Hickish T; Lofts F; Jodrell D; Webb A; Tait D; Ross PJ; Shellito P; Oates JR
Eur J Cancer; 2005 Jul; 41(11):1551-9. PubMed ID: 16026692
[TBL] [Abstract][Full Text] [Related]
26. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer.
Innominato PF; Focan C; Gorlia T; Moreau T; Garufi C; Waterhouse J; Giacchetti S; Coudert B; Iacobelli S; Genet D; Tampellini M; Chollet P; Lentz MA; Mormont MC; Lévi F; Bjarnason GA;
Cancer Res; 2009 Jun; 69(11):4700-7. PubMed ID: 19470769
[TBL] [Abstract][Full Text] [Related]
27. Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival.
Lévi F; Dugué PA; Innominato P; Karaboué A; Dispersyn G; Parganiha A; Giacchetti S; Moreau T; Focan C; Waterhouse J; Spiegel D;
Chronobiol Int; 2014 Oct; 31(8):891-900. PubMed ID: 24927369
[TBL] [Abstract][Full Text] [Related]
28. Home-Based e-Health Platform for Multidimensional Telemonitoring of Symptoms, Body Weight, Sleep, and Circadian Activity: Relevance for Chronomodulated Administration of Irinotecan, Fluorouracil-Leucovorin, and Oxaliplatin at Home-Results From a Pilot Study.
Innominato P; Komarzynski S; Karaboué A; Ulusakarya A; Bouchahda M; Haydar M; Bossevot-Desmaris R; Mocquery M; Plessis V; Lévi F
JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652550
[TBL] [Abstract][Full Text] [Related]
29. Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status.
Mormont MC; Langouët AM; Claustrat B; Bogdan A; Marion S; Waterhouse J; Touitou Y; Lévi F
Chronobiol Int; 2002 Jan; 19(1):141-55. PubMed ID: 11962672
[TBL] [Abstract][Full Text] [Related]
30. Contribution of the rest-activity circadian rhythm to quality of life in cancer patients.
Mormont MC; Waterhouse J
Chronobiol Int; 2002 Jan; 19(1):313-23. PubMed ID: 11962684
[TBL] [Abstract][Full Text] [Related]
31. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer.
Berger AM; Grem JL; Visovsky C; Marunda HA; Yurkovich JM
Oncol Nurs Forum; 2010 Nov; 37(6):E359-69. PubMed ID: 21059569
[TBL] [Abstract][Full Text] [Related]
32. An integrated psychological strategy for advanced colorectal cancer patients.
Pugliese P; Perrone M; Nisi E; Garufi C; Giannarelli D; Bottomley A; Terzoli E
Health Qual Life Outcomes; 2006 Feb; 4():9. PubMed ID: 16460566
[TBL] [Abstract][Full Text] [Related]
33. Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome.
Mormon MC; Bogdan A; Cormont S; Touitou Y; Lévi F
Anticancer Res; 2002; 22(2B):1243-9. PubMed ID: 12168933
[TBL] [Abstract][Full Text] [Related]
34. Correlation between rest-activity rhythm and survival in cancer patients experiencing pain.
Chang WP; Lin CC
Chronobiol Int; 2014 Oct; 31(8):926-34. PubMed ID: 24984030
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment.
Chong MY; Frenken KG; Eussen SJPM; Koster A; Pot GK; Breukink SO; Janssen-Heijnen M; Keulen ETP; Bijnens W; Buffart LM; Meijer K; Scheer FAJL; Steindorf K; de Vos-Geelen J; Weijenberg MP; van Roekel EH; Bours MJL
Int J Behav Nutr Phys Act; 2024 May; 21(1):51. PubMed ID: 38698447
[TBL] [Abstract][Full Text] [Related]
36. The circadian timing system in clinical oncology.
Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
[TBL] [Abstract][Full Text] [Related]
37. Circadian rhythmometry of serum endogenous tumor necrosis factor-alpha in patients with colorectal cancer metastases.
Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
Eur Cytokine Netw; 1998 Jun; 9(2):193-6. PubMed ID: 9681396
[TBL] [Abstract][Full Text] [Related]
38. Relationships of Circadian Rhythms and Physical Activity With Objective Sleep Parameters in Lung Cancer Patients.
Chen HM; Wu YC; Tsai CM; Tzeng JI; Lin CC
Cancer Nurs; 2015; 38(3):215-23. PubMed ID: 24945266
[TBL] [Abstract][Full Text] [Related]
39. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
Sultan A; Choudhary V; Parganiha A
Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
[TBL] [Abstract][Full Text] [Related]
40. Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy.
Rogers VE; Zhu S; Mandrell BN; Ancoli-Israel S; Liu L; Hinds PS
Support Care Cancer; 2020 Mar; 28(3):1459-1467. PubMed ID: 31273507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
